Adaptimmune Therapeutics (ADAP) Earnings Date & Reports

Industry: @Biotechnology

A.I. Advisor

published Earnings

ADAP is expected to report earnings to fall 490.20% to -19 cents per share on November 06

Adaptimmune Therapeutics ADAP Stock Earnings Reports

Q3'24

Est.

$-0.20

Q2'24

Beat

by $0.09

Q1'24

Beat

by $0.12

Q4'23

Beat

by $0.13

Q3'23

Beat

by $0.14

The last earnings report on August 12 showed earnings per share of 5 cents, beating the estimate of -3 cents. With 1.12M shares outstanding, the current market capitalization sits at 249.91M.

View a ticker or compare two or three

Compare

ADAP

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For ADAP
(Try 14 days for $1 only)

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

a manufacturer of vaccines and cancer immunotherapy products

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

60 Jubilee Avenue

Phone

+44 1235430000

Employees

449

Web

https://www.adaptimmune.com